Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma (I-MAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04291885
Recruitment Status : Recruiting
First Posted : March 2, 2020
Last Update Posted : July 20, 2021
Sponsor:
Information provided by (Responsible Party):
Melanoma and Skin Cancer Trials Limited

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2025
Estimated Study Completion Date : December 2028